Skip to main content
logo
Bio Medica Laboratories Limited (NSE:BMLL)
India flag India · Delayed Price · Currency is INR
141.45
+2.75 (1.98%)
At close: Jul 27, 2026

Bio Medica Laboratories Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
431.13431.13381.95152.49162.28212.25
Revenue Growth
103.12%12.88%150.47%-6.03%-23.54%64.21%
Gross Profit
256.3256.3178.7285.0746.5844.45
Operating Income
185.1185.1144.9245.2812.1415.65
Net Income
117.81117.8197.9526.313.65.89
Earnings Per Share
12.9512.9510.672.870.390.64
EPS Growth
1918.39%21.37%272.24%631.22%-38.90%34.11%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
1.041.040.070.10.0615.28
Total Debt
399.89399.89150.14104.996.07109.6
Net Cash (Debt)
-398.86-398.86-150.08-104.8-96.01-94.32
Net Cash Growth
------
Net Cash Per Share
-43.84-43.84-16.35-11.42-10.46-10.27

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-60.35-60.35-36.72-7.886.52-
Capital Expenditures
---0.19-15.26-17.1-
Free Cash Flow
-60.35-60.35-36.91-23.13-10.58-
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
59.45%59.45%46.79%55.79%28.70%20.94%
Operating Margin
42.94%42.94%37.94%29.69%7.48%7.37%
Pretax Margin
37.70%37.70%34.41%23.41%3.01%3.76%
Profit Margin
27.32%27.32%25.64%17.26%2.22%2.77%
FCF Margin
-14.00%-14.00%-9.66%-15.17%-6.52%-